Chronic oral administration of fenretinide, as a chemopreventive agent to breast cancer patients, does not affect plasma alpha-tocopherol concentration [3]

F. Formelli, M. Clerici, G. De Palo, A. Costa, U. Veronesi

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)446-447
Number of pages2
JournalAnnals of Oncology
Issue number6
Publication statusPublished - 1991

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this